In a whole new approach to asthma research, scientists at Yale have discovered that a molecule called Vascular Endothelial Growth Factor (VEGF) likely plays an important role in the development of the disease and raises the possibility of new asthma...
The National Cancer Institute recently awarded a five-year, $7.5 million program project grant to investigators at the Yale School of Medicine to continue studies on the role of viruses and mutant cellular proteins in tumorigenic transformation of cells...
Yale researcher Robert S. Sherwin, the C.N.H. Long Professor of Internal Medicine at Yale School of Medicine, is one of four physician-scientists recognized by Novartis Pharmaceuticals for significant and innovative research, clinical practice advances...
The St. Petersburg/New Haven Partnership for HIV/AIDS Care, Treatment and Support will be launched on today from 3 to 5 p.m., New Haven City Hall, 165 Church St. Opening remarks will be made by New Haven mayor The Honorable John DeStefano, Jr. and...
The Yale/Hartford Center of Excellence (CoE) in Aging has received renewed funding from the John A. Hartford Foundation to increase the amount of research, education and leadership in aging issues within medical specialties. The CoE, led by Mary E....
HistoRx, Inc., a bioscience company offering novel digital technologies for in situ diagnostics developed at Yale School of Medicine, has located its operations at 25 Science Park in New Haven. Their technology, called AQUA(tm) (Automated Quantitative...
Jeffrey S. Schechner, M.D., associate professor of dermatology at Yale School of Medicine, who was instrumental in advancing research on blood vessels in the skin and human skin grafting, died on September 7 in New Haven at age 39. Schechner, who also...
Researchers in the Department of Epidemiology and Public Health (EPH) at the Yale School of Medicine have been awarded a four year, $1.3 million grant from the National Cancer Institute to study the association between mammographic breast density and the...
Treating patients with a drug called aprotinin reduces the risk of stroke by 47 percent in patients undergoing coronary artery bypass graft (CABG) surgery, according to a study published in the Journal of Thoracic and Cardiovascular Surgery. The study...
Treatment to lower systolic high blood pressure in older persons is associated with substantial reduction of stroke and other cardiovascular diseases, Yale researchers report in the September 1 issue of Journal of the American Medical Association. The...